The Office of Research Compliance (ORC) is responsible for oversight, monitoring, development, and promulgation of policies and programs, and administration of review committees (where applicable) for the following compliance areas: 

Human Research Protections, Animal Research Protections, Use of Recombinant or Synthetic Nucleic Acid Molecules in Research,  Use of Stem Cells in Research,  Investigator Financial Conflicts of Interest, Laboratory Safety, Responsible Conduct in Research and Scholarship (RCRS), and Export Controls.

The ORC, through the Research Integrity Officer, receives allegations of research misconduct, and ensures compliance with University and federal policies and procedures governing such cases. 

Animal Use In Research

Biosafety in Research

CITI Training

Conflict of Interest

Controlled Substances In Research

Export Controls

Human Subjects In Research


Radioactive Drug Metabolism Research

Research Misconduct

Responsible Conduct of Research and Scholarship

Stem Cells Research


Disclosures must be filed:

At the time of submission to the Office of Sponsored Program (OSP) of a proposal for funding


Within 30 days of discovering or acquiring a new Significant Financial Interest 

and (PHS/NIH Only)

At least annually, commencing with, and on the anniversary of, the date of award, during the period of award. This is important because it means that if you are an investigator on a submission that is currently being considered for funding by PHS, you will need to file a disclosure as soon as you are aware that an award is forthcoming, and no later than the issue date of the award, if that date is after the effective date of the new PHS policy, i.e., August 24th. 

A Significant Financial Interest (SFI) is one or more of the following interests that you (or your spouse or dependent children) hold that reasonably appears to be related to your institutional responsibilities.

Institutional Responsibilities are those duties you have and activities you do as part of your professional responsibilities at SBU, including, e.g., research, research consultation, teaching, professional practice, institutional committee memberships, and service on panels such as Institutional Review Boards or Data and Safety Monitoring Boards.) 

…reasonably appears to be related to your institutional responsibilities…” means that if either your identified interests below, or the entity in which you have those interests, relies upon the same expertise utilized to carry out your Institutional responsibilities, it is considered an SFI. So, let's say you on a speaker's bureau for a company and present on topics related to the expertise you need to do your job at SBU. That would be a related interest. What if you were a paid board trustee for a religious organization? No, not related if you are an endocrinologist at SBU. Yes, related if you are a faculty member in Religious Studies. Now let's say you are a paid member on a company's board. In this situation, it's not what you do for the company (serve as a board member, which may not be something you do at SBU), but what the company's business is that must be considered in determining relatedness.  

  1. Financial interest in any publicly traded entity where the value of any remuneration (including salary and any payment for services not otherwise identified as salary, e.g., consulting fees, honoraria, paid authorship) received from the entity in the twelve months preceding this disclosure and the value of any equity interest (including stock, stock option, or other ownership interest, as determined through reference to public prices or other reasonable measures of fair market value)  in the entity as of the date of disclosure, when added together, exceeds $5,000.  
  2. Financial interest in any non-publicly traded entity where the value of any remuneration (including salary and any payment for services not otherwise identified as salary, e.g., consulting fees, honoraria, paid authorship) received from the entity in the twelve months preceding the disclosure, when aggregated, exceeds $5,000.
  3. Any equity interest (e.g., stock, stock option, or other ownership interest) in any non-publicly traded entity.
  4. Receipt of income over the past 12 months from royalty and other forms of payments in excess of (when aggregated) $5,000 resulting from successful commercialization of intellectual property rights and interests (e.g., patents, copyrights) licensed to any commercial entity or to the Research Foundation of SBU
  5. Travel (PHS Only)   You must disclose any reimbursed travel or sponsored travel (i.e., that which is paid on your behalf) that occurred in the twelve months preceding this disclosure, if it was related to your institutional responsibilities (i.e., the purpose of the travel relies upon the same expertise used to carry out your institutional responsibilities). You may also disclose the anticipated occurrence of such travel (up to in advance of one year). Excluded from this travel disclosure requirement is travel that is reimbursed or sponsored by federal, state or local government agency, a United States institution of higher education as defined at 20 U.S.C. 1001(a), an academic teaching hospital, a medical center, or a research institute that is affiliated with an Institution of higher education.

Yes. All investigators must complete FCOI training at least once every 4 years.

The purpose of the campus policy is to inform and educate the University community of their responsibilities to comply with federal export control regulations. Please see document for more details.

Events and Training

There are currently no upcoming events.

Go to top